Michiyuki Suzuki

Orexin-A (hypocretin-1) is possibly involved in generation of anxiety-like behavior

Michiyuki Suzuki, Carsten T. Beuckmann, Kohdoh Shikata et al. · Brain Research · 2005 · 160 citations

Life Sciences, Neurobiology, Neuroscience +9

In Vitro and In Silico Characterization of Lemborexant (E2006), a Novel Dual Orexin Receptor Antagonist

Carsten T. Beuckmann, Michiyuki Suzuki, Takashi Ueno et al. · Journal of Pharmacology and Experimental Therapeutics · 2017 · 110 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Classical eyeblink conditioning in glutamate receptor subunit δ2 mutant mice is impaired in the delay paradigm but not in the trace paradigm

Yasushi Kishimoto, Shigenori Kawahara, Michiyuki Suzuki et al. · European Journal of Neuroscience · 2001 · 101 citations

Life Sciences, Neurobiology, Neuroscience +15

Discovery of (1<i>R</i>,2<i>S</i>)-2-{[(2,4-Dimethylpyrimidin-5-yl)oxy]methyl}-2-(3-fluorophenyl)-<i>N</i>-(5-fluoropyridin-2-yl)cyclopropanecarboxamide (E2006): A Potent and Efficacious Oral Orexin Receptor Antagonist

Yu Yoshida, Yoshimitsu Naoe, Taro Terauchi et al. · Journal of Medicinal Chemistry · 2015 · 84 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Preclinical in vivo characterization of lemborexant (E2006), a novel dual orexin receptor antagonist for sleep/wake regulation

Carsten T. Beuckmann, Takashi Ueno, Makoto Nakagawa et al. · SLEEP · 2019 · 49 citations · Full text

Medicine, Neuroscience, Pharmacology +16